How is hypofibrinogenemia diagnosed in an infant?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diagnosis of Hypofibrinogenemia in Infants

The diagnosis of hypofibrinogenemia in infants requires measurement of fibrinogen levels from umbilical cord blood at birth, with collaboration between neonatal and pediatric bleeding disorder teams to confirm the diagnosis before performing any elective invasive procedures. 1

Diagnostic Approach

Initial Evaluation

  • For infants with suspected hypofibrinogenemia (especially those with family history):
    • Draw fibrinogen level from umbilical cord blood immediately after birth 1
    • This initial sample reflects the baby's true fibrinogen level before any interventions

Laboratory Testing

  • Fibrinogen activity level measurement is the primary diagnostic test 1
  • Fibrinogen antigen level should be measured when available 1
  • Additional coagulation tests that may show abnormalities:
    • Prolonged thrombin time
    • Prolonged partial thromboplastin time (APTT)
    • Prolonged prothrombin time (PT) 2

Interpretation Challenges

  • Critical pitfall: Adult reference ranges cannot be applied to newborns and infants 3
  • Age-specific reference ranges must be used:
    • Mean fibrinogen values are typically within adult range at birth
    • PT values reach adult range by day 4 of life
    • APTT values remain higher than adult range even at 11-20 days of life 3

Classification of Severity

Fibrinogen disorders are classified based on fibrinogen levels:

  • Afibrinogenemia: Complete absence of fibrinogen
  • Severe hypofibrinogenemia: Very low fibrinogen levels
  • Moderate hypofibrinogenemia: Low but detectable levels
  • Mild hypofibrinogenemia: Levels ≥1 g/L to lower limit of normal 1

Clinical Presentation

Infants with hypofibrinogenemia may present with:

  • Umbilical cord bleeding 2
  • Ecchymoses
  • Subcutaneous hematomas
  • Hemarthroses (especially following traumatic delivery)
  • Gastrointestinal bleeding 2

Management Considerations

Immediate Post-Diagnosis Care

  • Delay all elective invasive procedures (including venipuncture and circumcision) until diagnosis is confirmed 1
  • Establish collaboration between neonatal and pediatric bleeding disorder teams 1

Precautions During Procedures

  • For infants with confirmed afibrinogenemia or severe hypofibrinogenemia:
    • Avoid invasive procedures when possible
    • If procedures are necessary, maintain fibrinogen levels ≥1.5 g/L 1

Special Considerations

Maternal-Fetal Implications

  • When both parents are heterozygous for hypofibrinogenemic mutations:
    • 25% chance of having a child with afibrinogenemia
    • Prenatal diagnosis may be considered to assess fetal bleeding risks 1
    • Plan appropriate mode of delivery to minimize trauma

Delivery Planning

  • For infants suspected to have afibrinogenemia or severe hypofibrinogenemia:
    • Avoid fetal scalp monitoring
    • Avoid forceps or vacuum-assisted delivery
    • Consider early recourse to cesarean section, especially with prolonged second stage of labor 1

By following this diagnostic approach and taking appropriate precautions, clinicians can minimize bleeding complications and optimize outcomes for infants with hypofibrinogenemia.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Congenital Hypofibrinogenemia: A Newborn Infant with Cord Bleeding.

Turkish journal of haematology : official journal of Turkish Society of Haematology, 2000

Research

Routine coagulation tests in newborn and young infants.

Journal of thrombosis and thrombolysis, 2007

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.